AAAAAA

   
Results: 1-8 |
Results: 8
Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia
Authors: Devriendt, K Kim, AS Mathijs, G Frints, SGM Schwartz, M Van den Oord, JJ Verhoef, GEG Boogaerts, MA Fryns, JP You, DQ Rosen, MK Vandenberghe, P
Citation: K. Devriendt et al., Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia, NAT GENET, 27(3), 2001, pp. 313-317
P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia
Authors: van der Kolk, DM de Vries, EGE van Putten, WLJ Verdonck, LF Ossenkoppele, GJ Verhoef, GEG Vellenga, E
Citation: Dm. Van Der Kolk et al., P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia, CLIN CANC R, 6(8), 2000, pp. 3205-3214
Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review
Authors: Maertens, J Lagrou, K Deweerdt, H Surmont, I Verhoef, GEG Verhaegen, J Boogaerts, MA
Citation: J. Maertens et al., Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review, ANN HEMATOL, 79(6), 2000, pp. 340-344
Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests
Authors: Janssen, JJWM van Rijn, RS van der Holt, B Schuurhuis, GJ Vellenga, E Verhoef, GEG Ossenkoppele, GJ van den Berg, E Hagemeijer, A Slater, R Nieuwint, AWM Cornelissen, JJ
Citation: Jjwm. Janssen et al., Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests, BONE MAR TR, 25(11), 2000, pp. 1147-1155
A randomized study of granulocyte colony-stimulating factor applied duringand after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group
Authors: Ossenkoppele, GJ van der Holt, B Verhoef, GEG Daenen, SMGJ Verdonck, LF Sonneveld, P Wijermans, PW van der Lelie, J van Putten, WLJ Lowenberg, B
Citation: Gj. Ossenkoppele et al., A randomized study of granulocyte colony-stimulating factor applied duringand after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group, LEUKEMIA, 13(8), 1999, pp. 1207-1213
Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis
Authors: Maertens, J Demuynck, H Verbeken, EK Zachee, P Verhoef, GEG Vandenberghe, P Boogaerts, MA
Citation: J. Maertens et al., Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis, BONE MAR TR, 24(3), 1999, pp. 307-312
Peripheral blood stem cell transplantation as an alternative to autologousmarrow transplantation in the treatment of acute myeloid leukemia?
Authors: Vellenga, E van Putten, WLJ Boogaerts, MA Daenen, SMGJ Verhoef, GEG Hagenbeek, A Jonkhoff, AR Huijgens, PC Verdonck, LF van der Lelie, J Schouten, HC Gmur, J Wijermans, P Gratwohl, A Hess, U Fey, MF Lowenberg, B
Citation: E. Vellenga et al., Peripheral blood stem cell transplantation as an alternative to autologousmarrow transplantation in the treatment of acute myeloid leukemia?, BONE MAR TR, 23(12), 1999, pp. 1279-1282
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma
Authors: Segeren, CM Sonneveld, P van der Holt, B Baars, JW Biesma, DH Cornellissen, JJ Croockewit, AJ Dekker, AW Fibbe, WE Lowenberg, B Kooy, MV van Oers, MHJ Richel, DJ Schouten, HC Vellenga, E Verhoef, GEG Wijermans, PW Wittebol, S Lokhorst, HM
Citation: Cm. Segeren et al., Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma, BR J HAEM, 105(1), 1999, pp. 127-130
Risultati: 1-8 |